Baseline characteristics in the Collaborative AtoRvastatin Diabetes Study (CARDS) in patients with Type 2 diabetes

M. J. Thomason, H. M. Colhoun, S. J. Livingstone, M. I. Mackness, D. J. Betteridge, P. N. Durrington, G. A. Hitman, H. A. W. Neil, J. H. Fuller, CARDS Investigators

    Research output: Contribution to journalArticlepeer-review

    18 Citations (Scopus)

    Abstract

    To describe baseline characteristics of patients in the Collaborative AtoRvastatin Diabetes Study (CARDS), a randomized, placebo-controlled trial of lipid lowering with atorvastatin 10 mg daily for the primary prevention of major cardiovascular events in patients with Type 2 diabetes.
    Original languageEnglish
    Pages (from-to)901-905
    Number of pages5
    JournalDiabetic Medicine
    Volume21
    Issue number8
    DOIs
    Publication statusPublished - Aug 2004

    Fingerprint Dive into the research topics of 'Baseline characteristics in the Collaborative AtoRvastatin Diabetes Study (CARDS) in patients with Type 2 diabetes'. Together they form a unique fingerprint.

    Cite this